SCHEMBL4892092

SCHEMBL4892092

O=[N+]([O-])c1ccc(Cl)nc1Nc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.55
NPC1 O15118 4/20 0.55
LMNA P02545 3/20 0.55
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 3/20 0.55
RAB9A P51151 2/20 0.55
MITF O75030 2/20 0.55
TXNRD1 Q16881 2/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HTT P42858 3/20 0.51
NOD2 Q9HC29 1/20 0.51
FGFR4 P22455 2/20 0.51
GAA P10253 1/20 0.48
PIN1 Q13526 1/20 0.47
TDP2 O95551 1/20 0.45
HSP90AA1 P07900 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP3 P42574 1/20 0.45
BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695546 0.84 NPC1 (0.62) MAPTNPC1LMNAALDH1A1KDM4E
SCHEMBL4896581 0.83 KDM4E (0.52) MAPTNPC1LMNAALDH1A1KDM4E
SCHEMBL23410331 0.83 FGFR4 (0.51) MAPTNPC1LMNAALDH1A1KDM4E
SCHEMBL6804094 0.82 MAPT (0.60) MAPTNPC1LMNAALDH1A1KDM4E
SCHEMBL901887 0.82 FGFR4 (0.53) MAPTLMNAALDH1A1KDM4ETXNRD1
SCHEMBL1600402 0.81 PIN1 (0.65) MAPTALDH1A1TXNRD1MEN1KMT2A
SCHEMBL5301989 0.79 MAPT (0.55) MAPTNPC1LMNAALDH1A1KDM4E
SCHEMBL2191930 0.78 MAPK1 (0.57) MAPTNPC1LMNAALDH1A1RAB9A
SCHEMBL2193646 0.76 MAPT (0.51) MAPTLMNAALDH1A1TXNRD1MEN1
SCHEMBL4929418 0.76 MEN1 (0.61) MAPTNPC1LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
CN-1980923-A Polycyclic pyridines as potassium ion channel modulators ICAGEN INC (US) 2007-06-13 CN disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 MAPT 2710/4885NPC1 1509/4885LMNA 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.